Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Alexander Prejbisz"'
Autor:
Christina Pamporaki, PD, Annika M A Berends, PhD, Angelos Filippatos, ProfPhD, Tamara Prodanov, PhD, Leah Meuter, MD, Alexander Prejbisz, ProfPhD, Felix Beuschlein, ProfPhD, Martin Fassnacht, ProfPhD, Henri J L M Timmers, ProfPhD, Svenja Nölting, ProfPhD, Kaushik Abhyankar, Dipl-Ing, Georgiana Constantinescu, MD, Carola Kunath, Robbert J de Haas, PhD, Katharina Wang, Staatsexa, Hanna Remde, PhD, Stefan R Bornstein, ProfPhD, Andrzeij Januszewicz, ProfPhD, Mercedes Robledo, ProfPhD, Jacques W M Lenders, ProfPhD, Michiel N Kerstens, PhD, Karel Pacak, ProfDrSc, Graeme Eisenhofer, ProfPhD
Publikováno v:
The Lancet: Digital Health, Vol 5, Iss 9, Pp e551-e559 (2023)
Summary: Background: Pheochromocytomas and paragangliomas have up to a 20% rate of metastatic disease that cannot be reliably predicted. This study prospectively assessed whether the dopamine metabolite, methoxytyramine, might predict metastatic dise
Externí odkaz:
https://doaj.org/article/1f2317257660451eb856fc839fb1ec17
Autor:
Chritina Pamporaki, Annika M.A. Berends, Angelos Filippatos, Tamara Prodanov, Leah Meuter, Alexander Prejbisz, Felix Beuschlein, Martin Fassnacht, Henri J.L.M Timmers, Svenja Nölting, Kaushik Abhyankar, Georgiana Constantinescu, Carola Kunath, Robbert J. de Haas, Katharina Wang, Hanna Remde, Stefan R. Bornstein, Andrzeij Januszewicz, Mercedes Robledo, Jacques W.M. Lenders1, Michiel N. Kerstens, Karel Pacak, Graeme Eisenhofer
Background: Pheochromocytomas and paragangliomas (PPGL) have up to 20% rate of metastatic disease that cannot be reliably predicted. This study prospectively assessed whether the dopamine metabolite, methoxytyramine, might predict metastatic disease,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9862affcd4146bd337691e2a1e9051c2
Autor:
Tracy A Williams, Jacques W M Lenders, Paolo Mulatero, Jacopo Burrello, Marietta Rottenkolber, Christian Adolf, Fumitoshi Satoh, Laurence Amar, Marcus Quinkler, Jaap Deinum, Felix Beuschlein, Kanako K Kitamoto, Uyen Pham, Ryo Morimoto, Hironobu Umakoshi, Aleksander Prejbisz, Tomaz Kocjan, Mitsuhide Naruse, Michael Stowasser, Tetsuo Nishikawa, William F Young, Celso E Gomez-Sanchez, John W Funder, Martin Reincke, Tracy Ann Williams, Richard J Auchus, Detlef K Bartsch, Rene Baudrand, Peyman Björklund, Morris J Brown, Robert M Carey, Cristiana Catena, John M Connell, Tanja Dekkers, Thomas J Fahey, Francesco Fallo, Carlos E. Fardella, Gilberta Giacchetti, Giuseppe Giraudo, Per Hellman, Andrzej Januszewicz, Kanako Kiriyama Kitamoto, Gregory A Kline, Franco Mantero, Barbra S Miller, Pierre-François Plouin, Alexander Prejbisz, Christian L Rump, Leonardo A Sechi, Franco Veglio, Jirí Widimský, Holger S Willenberg
Publikováno v:
The Lancet Diabetes & Endocrinology
Lancet Diabetes & Endocrinology, 5, 689-699
Lancet Diabetes & Endocrinology, 5, 9, pp. 689-699
Lancet Diabetes & Endocrinology, 5, 689-699
Lancet Diabetes & Endocrinology, 5, 9, pp. 689-699
Item does not contain fulltext BACKGROUND: Although unilateral primary aldosteronism is the most common surgically correctable cause of hypertension, no standard criteria exist to classify surgical outcomes. We aimed to create consensus criteria for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a08702a9f3ee538a1343d37b4a7fb4d0
https://hdl.handle.net/2066/177409
https://hdl.handle.net/2066/177409